FdaApplication
ANDA 208299
Identifiers
- fda_app_no: ANDA208299
Properties
| Property | Value |
|---|---|
| applicant_name | PRINSTON PHARMACEUTICAL INC |
| application_type | ANDA |
| approval_date | 2022-05-10 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ROFLUMILAST | ROFLUMILAST | 500MCG | TABLET;ORAL |
1 product